Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page removes a general government funding status notice; the study content and enrollment details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    No substantive changes to study details, eligibility criteria, endpoints, or enrollment were detected; any differences appear to be minor formatting and layout updates. These non-substantive changes do not affect the page's core purpose of conveying trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T20:52:37.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:51:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. No other page content appears affected.
    Difference
    0.1%
    Check dated 2025-09-29T04:10:01.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T21:47:23.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T18:15:09.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.